Scientists from Proteon Pharmaceuticals S.A., in collaboration with researchers from the Institute of Medical Biology Polish Academy of Sciences, have developed a new quantitative method for
Łódź, 21 July 2023 – Proteon Pharmaceuticals opens the Center for Bacteriophage Biotechnology in Łódź Proteon Pharmaceuticals is delighted to announce the inauguration of its groundbreaking
Łódź, 9 May 2022 – Janusz Wojciechowski, EU Commissioner for Agriculture, visited Proteon Pharmaceuticals today. Commissioner Wojciechowski’s visit to Proteon Pharmaceuticals is to get better acquainted
Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within aquaculture and livestock farming. Proteon Pharmaceuticals uses bacteriophages to reduce the need for antibiotics, improve on-farm performance and increase the sustainability of protein production.
PROTEON CONTINUES DIALOGUE WITH EU COMMISSION TO SECURE EARLY AUTHORIZATION In its first-ever evaluation of a bacteriophage feed additive, EFSA (European Food Safety Authority) concluded that BAFSAL® is safe for all avian species, consumers of derived poultry products, and does not pose a risk to the environment; The recognition of BAFASAL®’s safety by EFSA is
The partnership will bring the emerging bacteriophage technology to poultry producers to help mitigate antimicrobial resistance. Warsaw, September 9, 2020 – Proteon Pharmaceuticals, a Polish biotechnology company and leader in bacteriophage technology for livestock farming, today announced a strategic partnership with DuPont Animal Nutrition, a business unit of DuPont Nutrition & Biosciences (DuPont) in distribution
In 2008, a superbug caught from a New Delhi hospital claimed the life of a Swedish patient. British scientists who found this “superbug” in New Delhi’s public water supply, named it New Delhi Metallo-beta-lactamase-1 after the Indian capital, causing much hue and cry in India. The drug resistant gene including its new variants has since
In response to the fight against coronavirus, Proteon Pharmaceuticals has joined the effort to create a new SARS-CoV-2 Coronavirus Detection Center in Lodz, Poland to conduct large-scale tests for virus diagnosis. The new laboratory was created at a very fast pace with the involvement and cooperation of the Institute of Medical Biology of the Polish
A Łódź pharmaceutical company has received over 2 million Euros to reduce animal antibiotics in the human food chain. In an attempt to find a solution to the well-known overuse of antibiotics in animals farmed for human consumption, the use of which has led to an increase in antibiotic resistant bacteria strains